Page 5 - Kiran Mazumdar-shaw

Infosys says Kiran Mazumdar-Shaw sold 1,600 shares without pre-clearance

The Trade was carried out by the portfolio manager without the knowledge of Ms Mazumdar-Shaw

Biocon's US generic formulations grew seven-fold in Q3: Kiran Mazumdar-Shaw

Biocon's year-to-date earnings have more than doubled over last year, led by the biologics segment, says Shaw

Kiran Shaw, Kannada Development Authority spar over English medium classes

A war of words has erupted between Biocon chief Kiran Mazumdar Shaw and Kannada Development Authority after she called the KDA "an insignificant group of nay sayers" for opposing the state government's proposal to introduce English medium classes in 1,000 primary schools. "Media always portrays a small & insignificant group of nay sayers as 'activists' - these r usually attention seeking trouble makers who don't care about education nor employment (sic)," Shaw tweeted on July 7, referring to KDA's stand on the issue. That day the KDA chairman had led a delegation to Chief Minister H D Kumaraswamy, urging him to rollback the proposal to introduce English medium classes in the schools and instead encourage education in the mother tongue, Kannada. The delegation comprised freedom fighter H S Doreswamy and writers Chandrashekar Kambar, Chandrashekar Patil and M Chidanandamurthy. Responding to KDA's stand, Shaw said "political malcontents" are trying to play mischief with her tweets ...

Price controls will devalue healthcare system in India: Kiran Mazumdar-Shaw

Kiran Mazumdar Shaw, chairman and managing director of Biocon has called on the Centre to be careful in controlling prices of drugs and equipment saying that this could potentially impact the quality of healthcare in India. "I think there is an affordability price-point which people need to understand and that is the debate we are not having. Just by forcing pricing on hospital services and drugs, what is happening today? There is a drug shortage, poor quality drug being offered. If you want cheap (more price control) you will devalue the entire healthcare system in India. I think the cost of healthcare in India is the lowest in the world and let us not forget that. You are not going to have quality stents and implants to use in surgery, are not you doing a disservice to patients," said Shaw. She was talking to reporters here at an event to announce GE Healthcare's partnership with medtech startup UE LifeSciences. National Pharmaceuticals Pricing Authority (NPPA) has recently ...

Ban open burning of all wastes, says Biocon's Kiran Mazumdar-Shaw

Mazumdar-Shaw said air pollution is a serious hazard which has already taken its toll in Delhi

Kiran Mazumdar-Shaw: e-health push can build 'Swastha Bharat'

In 2017 govt should push for increased adoption of technology to transform public health care system

Kiran Mazumdar-Shaw silences Twitter trolls with a 78% Biocon stock rally

It was the best return among shares of generic drugmakers worldwide

India witnessing 'jobless' growth: Kiran Mazumdar-Shaw

India, she said, needs pragmatic and visionary e-regulations that can unleash the power of e-commerce.

Future jobs to be driven by digital technology: Kiran Mazumdar-Shaw

She also said that e-businesses are the future and jobs would transition from conventional to new

Licence Raj replaced by time-consuming Approval Raj: Kiran Mazumdar-Shaw

The Biocon CMD also said that automation is boosting efficiency and GDP growth but not creating jobs

Opened up Pandora's box: Kiran Mazumdar-Shaw on Brexit

She said India cannot be in denial that it will be immune to Brexit

We can be very aggressive in US, EU with biosimilars: Kiran Mazumdar-Shaw

Shaw talks about Biocon's plans to make four filings in the US and Europe

Give fair chance to Mallya, stop media trial: Mazumdar-Shaw

Mazumdar-Shaw, however, said there are many companies which have large debts even though they have not been declared as defaulters